Burloiu A, Ozon E, Musuc A, Anastasescu M, Socoteanu R, Atkinson I
Gels. 2024; 10(8).
PMID: 39195028
PMC: 11353948.
DOI: 10.3390/gels10080499.
Remiro P, Nagahara M, Azoubel R, Franz-Montan M, dAvila M, Moraes A
Pharmaceutics. 2023; 15(1).
PMID: 36678640
PMC: 9864928.
DOI: 10.3390/pharmaceutics15010012.
Kurmaz S, Ignatiev V, Emelyanova N, Kurmaz V, Konev D, Balakina A
Pharmaceutics. 2022; 14(12).
PMID: 36559068
PMC: 9784683.
DOI: 10.3390/pharmaceutics14122572.
Mitrevska K, Cernei N, Michalkova H, Rodrigo M, Sivak L, Heger Z
Front Oncol. 2022; 12:986045.
PMID: 36212465
PMC: 9535364.
DOI: 10.3389/fonc.2022.986045.
Popovici V, Matei E, Cozaru G, Bucur L, Gird C, Schroder V
Pharmaceutics. 2022; 14(9).
PMID: 36145557
PMC: 9505056.
DOI: 10.3390/pharmaceutics14091808.
Fabrication and Evaluation of Buccal Mucoadhesive Tablet of Meloxicam.
Arabi M, Mortazavi S, Jafariazar Z, Farhadnejad H, Alipour Harisa G, Fatahi Y
Iran J Pharm Res. 2021; 19(3):63-76.
PMID: 33680010
PMC: 7758005.
DOI: 10.22037/ijpr.2019.111820.13378.
Countermeasures for Preventing and Treating Opioid Overdose.
France C, Ahern G, Averick S, Disney A, Enright H, Esmaeli-Azad B
Clin Pharmacol Ther. 2020; 109(3):578-590.
PMID: 33113208
PMC: 8193687.
DOI: 10.1002/cpt.2098.
Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms.
Desai H, Mahmoud M, Tan J, Minooei F, Demuth D, Steinbach-Rankins J
Pharmaceutics. 2020; 12(9).
PMID: 32882864
PMC: 7557775.
DOI: 10.3390/pharmaceutics12090835.
Cranberry extract-based formulations for preventing bacterial biofilms.
Greene A, Acharya A, Lee S, Gottardi R, Zaleski E, Little S
Drug Deliv Transl Res. 2020; 11(3):1144-1155.
PMID: 32783154
DOI: 10.1007/s13346-020-00837-x.
The Use of Poly(-vinyl pyrrolidone) in the Delivery of Drugs: A Review.
Franco P, De Marco I
Polymers (Basel). 2020; 12(5).
PMID: 32414187
PMC: 7285361.
DOI: 10.3390/polym12051114.
New Insights on the Mechanism of Fatty Acids as Buccal Permeation Enhancers.
Padula C, Pescina S, Nicoli S, Santi P
Pharmaceutics. 2018; 10(4).
PMID: 30355980
PMC: 6321376.
DOI: 10.3390/pharmaceutics10040201.
Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study.
McCulloch R, Sattar M, Henderson E, Lane M, Bluebond-Langner M
Palliat Med. 2017; 32(2):554-558.
PMID: 28631529
PMC: 5788078.
DOI: 10.1177/0269216317717192.
Dissolution Rate Enhancement, Design and Development of Buccal Drug Delivery of Darifenacin Hydroxypropyl β-Cyclodextrin Inclusion Complexes.
Jagdale S, Mohanty P, Chabukswar A, Kuchekar B
J Pharm (Cairo). 2015; 2013:983702.
PMID: 26556003
PMC: 4595963.
DOI: 10.1155/2013/983702.
In vitro evaluation of mucoadhesive films for gingival administration of lidocaine.
Padula C, Pozzetti L, Traversone V, Nicoli S, Santi P
AAPS PharmSciTech. 2013; 14(4):1279-83.
PMID: 23959703
PMC: 3840785.
DOI: 10.1208/s12249-013-0020-8.
COMPETING PROPERTIES OF MUCOADHESIVE FILMS DESIGNED FOR LOCALIZED DELIVERY OF IMIQUIMOD.
Ramineni S, Cunningham Jr L, Dziubla T, Puleo D
Biomater Sci. 2013; 1(7):753-762.
PMID: 23750320
PMC: 3673740.
DOI: 10.1039/C3BM60064E.
Influence of pH modifiers and HPMC viscosity grades on nicotine-magnesium aluminum silicate complex-loaded buccal matrix tablets.
Pongjanyakul T, Kanjanabat S
AAPS PharmSciTech. 2012; 13(2):674-85.
PMID: 22552930
PMC: 3364405.
DOI: 10.1208/s12249-012-9790-7.
Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs.
Rao S, Song Y, Peddie F, Evans A
Int J Nanomedicine. 2011; 6:1245-51.
PMID: 21753876
PMC: 3131191.
DOI: 10.2147/IJN.S19151.
Preparation and characterization of nicotine-magnesium aluminum silicate complex-loaded sodium alginate matrix tablets for buccal delivery.
Kanjanabat S, Pongjanyakul T
AAPS PharmSciTech. 2011; 12(2):683-92.
PMID: 21594728
PMC: 3134650.
DOI: 10.1208/s12249-011-9633-y.
Mucoadhesive drug delivery systems.
Shaikh R, Raghu Raj Singh T, Garland M, Woolfson A, Donnelly R
J Pharm Bioallied Sci. 2011; 3(1):89-100.
PMID: 21430958
PMC: 3053525.
DOI: 10.4103/0975-7406.76478.
Formulation of a novel tianeptine sodium orodispersible film.
El-Setouhy D, El-Malak N
AAPS PharmSciTech. 2010; 11(3):1018-25.
PMID: 20532710
PMC: 2974114.
DOI: 10.1208/s12249-010-9464-2.